Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Differential regulation of renal phospholipase C isoforms by catecholamines.
P Y Yu, … , G M Eisner, P A Jose
P Y Yu, … , G M Eisner, P A Jose
Published January 1, 1995
Citation Information: J Clin Invest. 1995;95(1):304-308. https://doi.org/10.1172/JCI117656.
View: Text | PDF
Research Article Article has an altmetric score of 3

Differential regulation of renal phospholipase C isoforms by catecholamines.

  • Text
  • PDF
Abstract

Dopamine and D1 agonists and NE all increase phosphatidyl inositol-specific phospholipase C (PLC) activity, but whereas dopamine produces a natriuresis, NE has an antinatriuretic effect. To determine if catecholamines differentially regulate the expression of PLC isoforms, we infused fenoldopam, a D1 agonist, or pramipexole, a D1/D2 agonist, intravenously or infused fenoldopam or NE into the renal artery of anesthetized rats. After 3-4 h of infusion, when the expected natriuresis (fenoldopam or pramipexole) or antinatriuresis (NE) occurred, the kidneys were removed for analysis of PLC isoform protein expression activity. Western blot analysis revealed that in renal cortical membranes, fenoldopam and pramipexole increased expression of PLC beta 1 and decreased expression of PLC gamma 1; PLC delta was unchanged. In the cytosol, pramipexole and fenoldopam increased expression of both PLC beta 1 and PLC gamma 1. No effects were noted in the medulla. A preferential D1 antagonist, SKF 83742, which by itself had no effect, blocked the effects of pramipexole, thus confirming the involvement of the D1 receptor. In contrast, NE also increased PLC beta 1 but did not affect PLC gamma 1 protein expression in membranes. The changes in PLC isoform expression were accompanied by similar changes in PLC isoform activity. These studies demonstrate for the first time differential regulation of PLC isoforms by catecholamines.

Authors

P Y Yu, L D Asico, G M Eisner, P A Jose

×

Total citations by year

Year: 2023 2016 2015 2014 2013 2011 2008 2007 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 1 1 1 2 1 1 1 2 4 2 1 3 5 7 4 1 1 39
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (39)

Title and authors Publication Year
Dopamine Receptor D(1)R and D(3)R and GRK4 Interaction in Hypertension.
Zeng C, Armando I, Yang J, Jose PA
The Yale journal of biology and medicine 2023
New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors
L Morla
World journal of biological chemistry 2016
Renal dopaminergic system: Pathophysiological implications and clinical perspectives
MR Choi
World Journal of Nephrology 2015
Signaling Pathways Involved in Renal Oxidative Injury: Role of the Vasoactive Peptides and the Renal Dopaminergic System
NL Mikusic, MC Kravetz, NM Kouyoumdzian, SL Penna, MI Rosón, BE Fernández, MR Choi
Journal of Signal Transduction 2014
Renal dopamine receptors, oxidative stress, and hypertension
S Cuevas, VA Villar, PA Jose, I Armando
International journal of molecular sciences 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Impairments of exploration and memory after systemic or prelimbic D1-receptor antagonism in rats
B Clausen, TR Schachtman, LT Mark, M Reinholdt, GR Christoffersen
Behavioural Brain Research 2011
Inhibitory effect of D 1 -like and D 3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells
Z Li, C Yu, Y Han, H Ren, W Shi, C Fu, D He, L Huang, C Yang, X Wang, L Zhou, LD Asico, C Zeng, PA Jose
American journal of physiology. Heart and circulatory physiology 2008
Oxidative stress reduces renal dopamine D1 receptor-G q/11 α G protein-phospholipase C signaling involving G protein-coupled receptor kinase 2
AA Banday, MF Lokhandwala
American journal of physiology. Renal physiology 2007
Dopamine D3receptor-mediated inhibition of Na+/H+exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells
R Pedrosa, P Gomes, C Zeng, U Hopfer, PA Jose, P Soares-da-Silva
British Journal of Pharmacology 2004
Functional genomics of the dopaminergic system in hypertension
C Zeng, H Sanada, H Watanabe, GM Eisner, RA Felder, PA Jose
Physiological genomics 2004
Structure and expression of the murine calcyon gene
R Dai, C Bergson
Gene 2003
Renal Dopamine Receptors and Hypertension
T Hussain, MF Lokhandwala
Experimental biology and medicine (Maywood, N.J.) 2003
Overexpression of PKC-βI and -δ contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats
M Asghar, T Hussain, MF Lokhandwala
American journal of physiology. Renal physiology 2003
Protein Kinase C Activation Downregulates Human Organic Anion Transporter 1-Mediated Transport through Carrier Internalization
NA Wolff, K Thies, N Kuhnke, G Reid, B Friedrich, F Lang, G Burckhardt
Journal of the American Society of Nephrology : JASN 2003
Role of dopamine receptors in the kidney in the regulation of blood pressure
PA Jose, GM Eisner, RA Felder
Current Opinion in Nephrology and Hypertension 2002
Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na + -K + -ATPase activity
P Gomes, P Soares-da-Silva
American journal of physiology. Renal physiology 2002
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
E Féraille, A Doucet
Physiological reviews 2001
Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells
S Nowicki, MS Kruse, H Brismar, A Aperia
American journal of physiology. Cell physiology 2000
Renal Protein Phosphatase 2A Activity and Spontaneous Hypertension in Rats
P Yu, LD Asico, GM Eisner, U Hopfer, RA Felder, PA Jose
Hypertension 2000
Dual Signaling Regulated by Calcyon, a D1 Dopamine Receptor Interacting Protein
N Lezcano, L Mrzljak, S Eubanks, R Levenson, P Goldman-Rakic, C Bergson
Science 2000
Fibroblast growth factor-2 stimulates phospholipase Cβ in adult cardiomyocytes
PS Tappia, RR Padua, V Panagia, E Kardami
Biochemistry and Cell Biology 1999
Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432
K Chergui, MG Lacey
Neuropharmacology 1999
Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension
H Sanada, PA Jose, D Hazen-Martin, PY Yu, J Xu, DE Bruns, J Phipps, RM Carey, RA Felder
Hypertension 1999
Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia
XH Lin, N Kitamura, T Hashimoto, O Shirakawa, K Maeda
Biological Psychiatry 1999
Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril
PS Tappia, SY Liu, S Shatadal, N Takeda, NS Dhalla, V Panagia
American journal of physiology. Heart and circulatory physiology 1999
Heterozygous knock-Out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse
LD Asico, C Ladines, S Fuchs, D Accili, RM Carey, C Semeraro, F Pocchiari, RA Felder, GM Eisner, PA Jose
Journal of Clinical Investigation 1998
Renal Dopamine Receptors in Health and Hypertension
PA Jose, GM Eisner, RA Felder
Pharmacology & Therapeutics 1998
Immunolocalization of phospholipase C isoforms in rat kidney
JP Lea, D Ertoy, JL Hollis, MB Marrero, JM Sands
Kidney International 1998
Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney
SL Parker, MS Parker, WR Crowley
Regulatory Peptides 1998
Heterozygous knock-Out of ET(B) receptors induces BQ-123-sensitive hypertension in the mouse
LD Asico, C Ladines, S Fuchs, D Accili, RM Carey, C Semeraro, F Pocchiari, RA Felder, GM Eisner, PA Jose
Journal of Clinical Investigation 1998
Renal Dopamine Receptor Function in Hypertension
T Hussain, MF Lokhandwala
Hypertension 1998
Dopamine D 1 Receptor and Protein Kinase C Isoforms in Spontaneously Hypertensive Rats
LP Yao, , PY Yu, J Xu, LD Asico, PA Jose
Hypertension 1998
Vascular Dopamine-I Receptors and Atherosclerosis
K Yasunari, M Kohno, H Kano, K Yokokawa, M Minami, J Yoshikawa
Journal of Atherosclerosis and Thrombosis 1997
Dopamine as a Novel Antimigration and Antiproliferative Factor of Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors
K Yasunari, M Kohno, T Hasuma, T Horio, H Kano, K Yokokawa, M Minami, J Yoshikawa
Arteriosclerosis, thrombosis, and vascular biology 1997
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release
J Harvey, M G Lacey
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997
A Postsynaptic Interaction between Dopamine D1 and NMDA Receptors Promotes Presynaptic Inhibition in the Rat Nucleus Accumbens via Adenosine Release
Harvey J, Lacey MG
Journal of Neuroscience 1997
Dopamine D 1A Receptor Regulation of Phospholipase C Isoform
PY Yu, GM Eisner, I Yamaguchi, MM Mouradian, RA Felder, PA Jose
The Journal of biological chemistry 1996
α1B-adrenergic receptors in rat renal microvessels
LM Canessa, MM Piccio, P Vachvanichsanong, A Sidhu, CC Porter, JE Robillard, RA Felder, PA Jose
Kidney International 1995

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
6 readers on Mendeley
See more details